Most Popular Articles

1 2 3 4 5

Injectable DaxibotulinumtoxinA for the Treatment of Glabellar Lines: A Phase 2, Randomized, Dose-Ranging, Double-Blind, Multicenter Comparison With OnabotulinumtoxinA and Placebo

Carruthers, Jean; Solish, Nowell; Humphrey, Shannon; More

Dermatologic Surgery. 43(11):1321-1331, November 2017.

ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin ...

Waldman, Abigail; Bolotin, Diana; Arndt, Kenneth A.; More

Dermatologic Surgery. 43(10):1249-1262, October 2017.

A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months

Sattler, Gerhard; Philipp-Dormston, Wolfgang G.; Van Den Elzen, Helga; More

Dermatologic Surgery. 43(2):238-245, February 2017.

1 2 3 4 5